Andrew C. G. Uprichard

Andrew C. G. Uprichard

66 year
Health Technology
Consumer Services

Profile

Andrew C.
G.
Uprichard
is President and Head-Research and Development of EPIX Pharmaceuticals, Inc., which he joined in July 2004.
He served as President and Chief Operating Officer of EPIX Pharmaceuticals.
From 2002 to 2003, Dr. Uprichard served as Chief Operating Officer of ArQule, Inc. and from 2000 to 2002 Curis, Inc. He spent 11 years with Parke-Davis Pharmaceutical Research, a division of Warner-Lambert and served as Vice President-Drug Development from 1997 to 2000 and Senior Director of Cardiovascular Pharmacology from 1994 to 1997.
From 1989 to 1994, Dr. Uprichard held various oversight positions in Cardiovascular Clinical Development.
In the late 1980s, he was a Cardiology and Postdoctoral Fellow at the University of Michigan Medical School.
Dr. Uprichard is a Fellow of the Royal College of Physicians of Edinburgh, the Faculty of Pharmaceutical Medicine and the American College of Physicians.
He received MB, ChB and MD degrees from the University of Edinburgh, Scotland.

Former positions of Andrew C. G. Uprichard

CompaniesPositionEnd
President 21/05/2008
ARQULE, INC. Chief Operating Officer 01/01/2003
CURIS, INC. Chief Operating Officer 01/01/2002
President -
Corporate Officer/Principal -
See the detail of Andrew C. G. Uprichard's experience

Training of Andrew C. G. Uprichard

The University of Edinburgh Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew C. G. Uprichard's experience

Connections

35

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
CURIS, INC.

Health Technology

Private companies4

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Andrew C. G. Uprichard